ALLcare Fertility Center – FDA 483, Nov 6, 2024
ALLCARE Fertility Center in New York, NY, was cited for multiple deficiencies related to donor eligibility determination and screening for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The inspection revealed failures in documenting donor eligibility, collecting specimens at appropriate times for communicable disease testing, and maintaining adequate procedures for donor screening. Additionally, the firm failed to properly label HCT/Ps not requiring donor eligibility determination and maintained inaccurate donor eligibility records.
ID · 13e19996-ff2e-4f30-b543-d8974fcfccd0
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.